リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Failure of internal fixation for ankle joint Charcot neuroarthropathy with beta(2)-microglobulin amyloidosis: a case report」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Failure of internal fixation for ankle joint Charcot neuroarthropathy with beta(2)-microglobulin amyloidosis: a case report

Zheng, Yang Zhang, Jiu-Dan Huang, Jie-Feng Zhu, Ya-Hong 名古屋大学

2023.03.01

概要

Charcot neuroarthropathy (CN) is a serious diabetic complication with a poor prognosis and a high rate of misdiagnosis. Furthermore, beta(2)-microglobulin amyloidosis (Abeta2M) makes the diagnosis and therapy more difficult and complex. This case report highlights the pathophysiology, clinical evaluation, treatment, and prevention of the major diabetic complications associated with CN and Abeta2M that cause poor quality of life, limit the patient’s ability to walk independently, and are directly or indirectly linked with a high risk for lower limb amputation. Ankle CN was discovered in a 36-year-old single female with a history of type 1 diabetes mellitus and diabetic nephropathy. We performed early internal fixation. However, because she lived alone and needed hemodialysis three times a week, wearing a brace and non-weight-bearing were extremely inconvenient. Furthermore, she did not experience any pain and only some edema; thus, she proceeded to bear weight ahead of schedule without authorization. Due to the premature weight-bearing and poor compliance, the patient suffered severe bone resorption and infection and eventually had to undergo amputation. Abeta2M was suggested by bone pathological sections. We present a case of failed internal fixation of ankle CN with Abeta2M, emphasizing the importance of social factors and postoperative management.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1 Schmidt BM, Holmes CM. Updates on Diabetic Foot and Charcot Osteopathic Arthropathy. Curr Diab Rep. 2018;18(10):74. doi:10.1007/s11892-018-1047-8.

2 Womack J. Charcot Arthropathy Versus Osteomyelitis: Evaluation and Management. Orthop Clin North Am. 2017;48(2):241–247. doi:10.1016/j.ocl.2016.12.011.

3 Ramanujam CL, Stuto AC, Zgonis T. Surgical treatment of midfoot Charcot neuroarthropathy with osteomy- elitis in patients with diabetes: a systematic review. J Wound Care. 2020;29(Sup6):S19-S28. doi:10.12968/ jowc.2020.29.Sup6.S19.

4 Lonnemann G, Koch KM. Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane. J Am Soc Nephrol. 2002;13 Suppl 1:S72-S77. doi:10.1681/ASN.V13suppl_1s72.

5 Marmolejo VS, Arnold JF, Ponticello M, Anderson CA. Charcot Foot: Clinical Clues, Diagnostic Strategies, and Treatment Principles. Am Fam Physician. 2018;97(9):594–599.

6 Trieb K. The Charcot foot: pathophysiology, diagnosis and classification. Bone Joint J. 2016;98-B(9):1155– 1159. doi:10.1302/0301-620X.98B9.37038.

7 Holmes C, Schmidt B, Munson M, Wrobel JS. Charcot stage 0: A review and consideratons for making the correct diagnosis early. Clin Diabetes Endocrinol. 2015;1:18. doi:10.1186/s40842-015-0018-0.

8 Lowery NJ, Woods JB, Armstrong DG, Wukich DK. Surgical management of Charcot neuroarthropathy of the foot and ankle: a systematic review. Foot Ankle Int. 2012;33(2):113–121. doi:10.3113/FAI.2012.0113.

9 Botek G, Figas S, Narra S. Charcot Neuroarthropathy Advances: Understanding Pathogenesis and Medical and Surgical Management. Clin Podiatr Med Surg. 2019;36(4):663–684. doi:10.1016/j.cpm.2019.07.002.

10 Schneekloth BJ, Lowery NJ, Wukich DK. Charcot Neuroarthropathy in Patients With Diabetes: An Up- dated Systematic Review of Surgical Management. J Foot Ankle Surg. 2016;55(3):586–590. doi:10.1053/j. jfas.2015.12.001.

11 Kroin E, Schiff A, Pinzur MS, Davis ES, Chaharbakhshi E, DiSilvio FA. Functional Impairment of Patients Undergoing Surgical Correction for Charcot Foot Arthropathy. Foot Ankle Int. 2017;38(7):705–709. doi:10.1177/1071100717701233.

12 Armstrong DG, Lavery LA. Acute Charcot’s arthropathy of the foot and ankle. Phys Ther. 1998;78(1):74–80. doi:10.1093/ptj/78.1.74.

13 Yates TH, Cooperman SR, Shofler D, Agrawal DK. Current concepts underlying the pathophysiology of acute Charcot neuroarthropathy in the diabetic foot and ankle. Expert Rev Clin Immunol. 2020;16(8):839–845. do i:10.1080/1744666X.2020.1804869.

14 Hartemann-Heurtier A, Van GH, Grimaldi A. The Charcot foot. Lancet. 2002;360(9347):1776–1779. doi:10.1016/S0140-6736(02)11671-0.

15 Wukich DK, Raspovic KM, Hobizal KB, Sadoskas D. Surgical management of Charcot neuroarthropathy of the ankle and hindfoot in patients with diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:292–296. doi:10.1002/dmrr.2748.

16 Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications. 2009;23(6):409–426. doi:10.1016/j.jdiacomp.2008.09.004.

17 Bullen B, Young M, McArdle C, Ellis M. Charcot neuroarthropathy patient education among podiatrists in Scotland: a modified Delphi approach. J Foot Ankle Res. 2018;11:54. doi:10.1186/s13047-018-0296-8.

18 Nilsen FA, Molund M, Hvaal KH. High Incidence of Recurrent Ulceration and Major Amputations Associ- ated With Charcot Foot. J Foot Ankle Surg. 2018;57(2):301–304. doi:10.1053/j.jfas.2017.10.008.

19 Heegaard NHH. beta(2)-microglobulin: from physiology to amyloidosis. Amyloid. 2009;16(3):151–173. doi:10.1080/13506120903151775.

参考文献をもっと見る